286 related articles for article (PubMed ID: 1444293)
1. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
Behre G; Schedel I; Nentwig B; Wörmann B; Essink M; Hiddemann W
Antimicrob Agents Chemother; 1992 Oct; 36(10):2139-46. PubMed ID: 1444293
[TBL] [Abstract][Full Text] [Related]
2. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome.
Strutz F; Heller G; Krasemann K; Krone B; Müller GA
Intensive Care Med; 1999 May; 25(5):435-44. PubMed ID: 10401935
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
4. Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation.
Jackson SK; Parton J; Barnes RA; Poynton CH; Fegan C
Eur J Clin Invest; 1993 Sep; 23(9):540-5. PubMed ID: 8243524
[TBL] [Abstract][Full Text] [Related]
5. [The therapy of gram-negative septicotoxic diseases with pentaglobin, an immunoglobulin with an elevated IgM content (a prospective, randomized clinical study)].
Schedel I; Dreichhausen U
Anesteziol Reanimatol; 1996; (3):4-9. PubMed ID: 8967617
[TBL] [Abstract][Full Text] [Related]
6. Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation.
Poynton CH; Jackson S; Fegan C; Barnes RA; Whittaker JA
Bone Marrow Transplant; 1992 Jun; 9(6):451-7. PubMed ID: 1628130
[TBL] [Abstract][Full Text] [Related]
7. [Immunoglobulin therapy of postoperative sepsis].
Wesoly C; Kipping N; Grundmann R
Z Exp Chir Transplant Kunstliche Organe; 1990; 23(4):213-6. PubMed ID: 2095647
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and potential clinical applications of Pentaglobin, an IgM-enriched immunoglobulin concentrate suitable for intravenous infusion.
Lissner R; Struff WG; Autenrieth IB; Woodcock BG; Karch H
Eur J Surg Suppl; 1999; (584):17-25. PubMed ID: 10890227
[TBL] [Abstract][Full Text] [Related]
9. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830].
Tugrul S; Ozcan PE; Akinci O; Seyhun Y; Cagatay A; Cakar N; Esen F
Crit Care; 2002 Aug; 6(4):357-62. PubMed ID: 12225613
[TBL] [Abstract][Full Text] [Related]
10. Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.
Nys M; Damas J; Damas P; Laub R; Cloes JM; Lamy M
Med Microbiol Immunol; 1999 Nov; 188(2):55-64. PubMed ID: 10753056
[TBL] [Abstract][Full Text] [Related]
11. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
[TBL] [Abstract][Full Text] [Related]
12. IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study.
Wand S; Klages M; Kirbach C; Warszawska J; Meybohm P; Zacharowski K; Koch A
PLoS One; 2016; 11(8):e0160907. PubMed ID: 27504630
[TBL] [Abstract][Full Text] [Related]
13. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.
Bone RC; Balk RA; Fein AM; Perl TM; Wenzel RP; Reines HD; Quenzer RW; Iberti TJ; Macintyre N; Schein RM
Crit Care Med; 1995 Jun; 23(6):994-1006. PubMed ID: 7774238
[TBL] [Abstract][Full Text] [Related]
14. Association of endotoxemia and production of antibodies against endotoxins after multiple injuries.
Buttenschoen K; Berger D; Strecker W; Buttenschoen DC; Stenzel K; Pieper T; Beger HG
J Trauma; 2000 May; 48(5):918-23. PubMed ID: 10823537
[TBL] [Abstract][Full Text] [Related]
15. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.
Roggen EL; Hoofd G; Van Dyck E; Piot P
Sex Transm Dis; 1994; 21(1):36-42. PubMed ID: 8140487
[TBL] [Abstract][Full Text] [Related]
16. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
[TBL] [Abstract][Full Text] [Related]
17. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
[TBL] [Abstract][Full Text] [Related]
18. IgM-enriched immunoglobulin preparation for immunoprophylaxis in cardiac surgery.
Friedrich I; Silber RE; Baumann B; Fischer C; Holzheimer RG
Eur J Med Res; 2002 Dec; 7(12):544-9. PubMed ID: 12527500
[TBL] [Abstract][Full Text] [Related]
19. Levels of antibodies to endotoxin and cytokine release in patients with severe trauma: does posttraumatic dysergy contribute to organ failure?
Pape HC; Remmers D; Grotz M; Schedel I; von Glinski S; Oberbeck R; Dahlweit M; Tscherne H
J Trauma; 1999 May; 46(5):907-13. PubMed ID: 10338411
[TBL] [Abstract][Full Text] [Related]
20. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
